Carmel Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,594
| Closed | -$2.3M | – | 26 |
|
|
2024
Q4 | $2.3M | Sell |
25,594
-10,275
| -29% | -$925K | 0.87% | 23 |
|
|
2024
Q3 | $3.54M | Sell |
35,869
-375
| -1% | -$37.1K | 1.33% | 23 |
|
|
2024
Q2 | $3.36M | Sell |
36,244
-4,515
| -11% | -$419K | 1.31% | 23 |
|
|
2024
Q1 | $3.87M | Buy |
40,759
+18,283
| +81% | +$1.73M | 1.59% | 23 |
|
|
2023
Q4 | $2.01M | Sell |
22,476
-600
| -3% | -$53.6K | 0.96% | 23 |
|
|
2023
Q3 | $1.69M | Sell |
23,076
-470
| -2% | -$34.3K | 0.95% | 23 |
|
|
2023
Q2 | $1.96M | Buy |
23,546
+675
| +3% | +$56.2K | 1.02% | 25 |
|
|
2023
Q1 | $1.74M | Buy |
22,871
+1,550
| +7% | +$118K | 1% | 27 |
|
|
2022
Q4 | $1.77M | Buy |
21,321
+2,625
| +14% | +$218K | 1.09% | 27 |
|
|
2022
Q3 | $1.48M | Buy |
18,696
+725
| +4% | +$57.5K | 0.97% | 29 |
|
|
2022
Q2 | $1.34M | Sell |
17,971
-9,715
| -35% | -$722K | 0.83% | 29 |
|
|
2022
Q1 | $2.49M | Buy |
27,686
+950
| +4% | +$85.4K | 1.3% | 26 |
|
|
2021
Q4 | $2.99M | Buy |
+26,736
| New | +$2.99M | 1.47% | 23 |
|